N/A
N=30
Triglyceride Effects on Blood Flow in the Human Brain
Alzheimer Disease
Bottom Line
View on ClinicalTrials.gov: NCT05218018 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Feb 2023
Primary outcome: Primary: Cerebral Blood Flow Global — -2.2 ml/100g/min — p=.002
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Lipid drink (Dietary_supplement)
- Age
- Adult, Older Adult · 55+ yrs
- Sex
- All
- Sponsor
- University of Washington
- Primary completion
- Jan 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cerebral Blood Flow Global |
-2.2 | .002 sig |
| PRIMARY Cerebral Blood Flow Change Scores |
-1.8; -2.2; -2.4 | — |
Summary
The 'Western diet' characterized by high fat feeding (HFF) is a risk factor for Alzheimer's disease (AD); however, little is known about mechanisms. Paradoxically, individuals who carry the AD risk gene APOE E4 cognitively improve after HFF and show different metabolic responses to fat intake. These responses include a more pronounced drop in systolic blood pressure and a decrease in cerebrospinal fluid glucose and lactate levels. This proposal will further examine the brain metabolic response to HFF using non-invasive imaging. Cerebral blood flow (CBF) as assessed by functional MRI is increasingly utilized to investigate brain function, given that CBF is tightly coupled to brain metabolism. Acute changes in CBF have been described in response to carbohydrate ingestion in regions important for learning and memory; however, no one has yet assessed CBF response to lipid. Here investigators propose to characterize CBF changes to a high fat drink in older adults. This study will include a time course assessment as well as analyses of global and regional change in CBF. These data would serve as feasibility pilot data for an R01 application which would include cognitive and peripheral metabolic data. These types of studies will provide a clearer picture of acute brain metabolic response to HFF in older adults, including the effects of APOE.
Eligibility Criteria
Inclusion Criteria
- Previously completed the Meal and Memory study
- Age 55 and older
- Able to read and understand English
- Able to give informed consent
- Able to undergo MRI and ingest dairy products
Exclusion Criteria
- Did not screen in the Meal and Memory study
- Allergic to or not able to ingest study ingredient (dairy)
- Metal in body or otherwise unable to lay still for an MRI
Data sourced from ClinicalTrials.gov (NCT05218018). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.